Prof Eliza Hawkes
elizahawkes.bsky.social
Chief Clinical Research Officer & Lymphoma Clinical Innovations Lab head At Olivia Newton John Cancer Research Institute. Lymphoma Lead At ONJCancerCentre Lymphoma Researcher Monash University #lymsm #hemesky #medsky Views are my own
👤 Joined on 10 November 2024
173
Followers
153
Following
21
Total Posts
📜 Kullanıcı Geçmişi
- 10 Kas 2024, 04:47
🎉 Bluesky'e katıldı - İlk kullanıcı adı:
@elizahawkes.bsky.social
🚫 Blokladığı Kullanıcılar
❤️ Beğendiği Gönderiler
📊 JAMA Guide to Statistics and Methods: The win ratio is a statistical method for hierarchical composite outcomes, offering a patient-centered summary of treatment effects by prioritizing more important clinical events in clinical trials. ja.ma/3Meleve
Show Post
ONJCRI is thrilled to announce that Prof Eliza Hawkes and Prof Hui Gan have received MRFF Clinical Trials Activity funding to lead new and impactful clinical trials for blood and brain cancer patients. ➡️ https://ow.ly/mEgi50XZUuX #ClinicalTrials #CancerTrials #Glioblastoma #Lymphoma #MRFF
Show Post
🚨 NEWS 🚨 FDA approves a subcutaneous formulation of mosunetuzumab for the treatment of adult patients with R/R FL after ≥2 prior lines of systemic therapy, based on results from the GO29781 trial. Read more: https://loom.ly/p7QgFmU #lymphoma #lymsm #MedNews #MedEd
Show Post🚨 NEWS 🚨 Japan's Ministry of Health, Labour and Welfare approves tafasitamab in combination with rituximab + lenalidomide for adult patients with R/R FL, based on data from the phase III inMIND trial. Read more: https://loom.ly/n4AYOKI #lymphoma #lymsm #mednews
Show Post
Thanks for all the great memories, my #ASH25 friends! Stay in touch, and looking forward to seeing your new abstracts at #ASH26. cc @ash.hematology.org
Show Post